Hsp90 has been proposed to inhibit the formation of oligomeric αSyn, further aggregation of which disrupts the mitochondrial membrane resulting in impaired mitochondrial function and the subsequent neuronal death in Parkinson’s disease [171]. Here, HSP90AB1 is linked to Parkinson disease.